Associations of Inosine with Gut Microbiota, Metabolic Indicators, and Fluid Homeostasis in Kidney-Related Diarrhea

Huiyi Peng1,2, Qin Liu1,2, Zhoujin Tan1,2

  • 1School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.

Insights

Inosine treatment improved kidney function and alleviated diarrhea in mice by reducing inflammation and altering gut bacteria. This purine metabolite also positively impacted metabolic status and fluid balance.

Area of Science:

  • Biochemistry
  • Microbiology
  • Nephrology

Background:

  • Kidney-related diarrhea pathogenesis is complex and linked to gut microbiota and metabolic dysregulation.
  • The role of inosine, a natural purine metabolite, in this condition is not well understood.
  • Investigating inosine's effects could reveal novel therapeutic strategies.

Purpose of the Study:

  • To investigate the effects of inosine on kidney-related diarrhea in a mouse model.
  • To explore inosine's impact on gut microbiota, metabolic status, and related signaling pathways.
  • To determine the potential of inosine as a therapeutic agent for kidney-related diarrhea.

Main Methods:

  • Induction of kidney-related diarrhea in male KM mice.
  • Histopathological analysis (HE staining) for tissue damage and inflammation.
  • ELISA for corticosterone (CORT), antidiuretic hormone (ADH), and adenosine triphosphate (ATP).
  • Immunohistochemistry (IHC), RT-qPCR, and Western blot (WB) for protein and gene expression (AQP4, AMPK, NF-κB, A2AR).
  • 16S rRNA sequencing for gut microbiota analysis and KEGG functional prediction.
  • Correlation analysis between microbiota and host factors.

Main Results:

  • Inosine treatment improved renal function and alleviated renal and colonic histopathological damage.
  • Inosine increased levels of ATP, ADH, and CORT, indicating enhanced metabolic status and fluid homeostasis.
  • Inosine modulated the A2AR/AMPK/NF-κB signaling pathway by upregulating A2AR, AMPK, and AQP4, and downregulating NF-κB.
  • Inosine altered gut microbial composition and predicted functional pathways, with significant correlations observed between specific bacteria and host indicators.

Conclusions:

  • Inosine effectively alleviates kidney-related diarrhea in mice.
  • The therapeutic effects are associated with improved metabolic status, fluid homeostasis, reduced inflammation, and modulation of the A2AR/AMPK/NF-κB pathway.
  • Inosine's impact on gut microbiota composition and function plays a role in its beneficial effects, warranting further investigation.

Related Concept Videos

Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...